Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Oral Proteins and Peptides refer to biological drugs of peptide and protein substances used for prevention, treatment and diagnosis. Polypeptide is a compound formed by linking α-amino acids with peptide chains. It is also an intermediate product of protein hydrolysis. N polypeptide chains are twisted and tangled according to a certain spatial structure to form a protein. Hydrolysis of macromolecular proteins produces peptides. Oral Proteins and Peptides are biochemical preparations, which require relatively strict storage and transportation environments.
The global Oral Proteins and Peptides market report provided by Global Market Monitor provides a detailed overview of the changes in the industry's market dynamics, and in-depth analysis of market segments by type and application. This report calculates the historical, current and projected market size by volume and value, and predicts recent industry trends and developments. This report describes in detail the current competitive landscape of the Oral Proteins and Peptides market, major competitors, and the product strategies that practitioners should adopt. This report shows practitioners the market segments and regions with growth potential, and shows their economic conditions, such as major regions, item values, profits, restrictions, power generation, supply, demand, and market development speed. The report also provides additional SWOT analysis, speculative accessibility research and risk-reward research.
In recent years, due to the increase in the prevalence of chronic diseases, the increase of patients' preference for oral drugs, and the increase of patients' dependence on patients, the global market's demand for Oral Proteins and Peptides has increased significantly. Secondly, the global aging degree is getting worse and the elderly population is increasing rapidly, which to a certain extent will promote the growth of the Oral Proteins and Peptides market. In addition, the government has spent more energy improving the medical environment, which is a valuable market opportunity for practitioners. However, the production cost of Oral Proteins and Peptides is extremely high, and the bioavailability of these drugs in the body is extremely low. These factors limit the growth of the market. In terms of market trends, the increase in R&D funding of pharmaceutical companies and the surge in purchasing power of emerging economies provide market participants with lucrative opportunities.
The report details the trend, potential and market size of Oral Proteins and Peptides market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Oral Proteins and Peptidesmarket, defines the market attractiveness level of Oral Proteins and Peptides market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Oral Proteins and Peptides industry, describes the types of Oral Proteins and Peptides market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oral Proteins and Peptides market and the development prospects and opportunities of Oral Proteins and Peptides industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oral Proteins and Peptides market in Chapter 13.
By Player:
Johnson & Johnson
ZydusCadilla Healthcare
Abbott Laboratories
Sanofi-Aventis LLC
Novartis AG
By Type:
Linaclotide
Plecanatide
Calcitonin
Insulin
Octreotide
By End-User:
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Oral Proteins and Peptides Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Oral Proteins and Peptides Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Oral Proteins and Peptides Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Oral Proteins and Peptides Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Oral Proteins and Peptides Market Analysis and Outlook to 2022
-
7.1 Global Oral Proteins and Peptides Consumption (2017-2022)
-
7.2 United States Oral Proteins and Peptides Consumption (2017-2022)
-
7.3 Europe Oral Proteins and Peptides Consumption (2017-2022)
-
7.4 China Oral Proteins and Peptides Consumption (2017-2022)
-
7.5 Japan Oral Proteins and Peptides Consumption (2017-2022)
-
7.6 India Oral Proteins and Peptides Consumption (2017-2022)
-
7.7 South Korea Oral Proteins and Peptides Consumption (2017-2022)
8 Region and Country-wise Oral Proteins and Peptides Market Analysis and Outlook to 2028
-
8.1 Global Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
8.2 United States Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
8.3 Europe Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
8.4 China Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
8.5 Japan Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
8.6 India Oral Proteins and Peptides Consumption Forecast (2022-2028)
-
8.7 South Korea Oral Proteins and Peptides Consumption Forecast (2022-2028)
9 Global Oral Proteins and Peptides Market Outlook by Types and Applications to 2022
-
9.1 Global Oral Proteins and Peptides Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Linaclotide Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Plecanatide Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Calcitonin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Insulin Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Octreotide Consumption and Growth Rate (2017-2022)
-
9.2 Global Oral Proteins and Peptides Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Gastric & Digestive Disorders Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Bone Diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Hormonal Disorders Consumption and Growth Rate (2017-2022)
10 Global Oral Proteins and Peptides Market Outlook by Types and Applications to 2028
-
10.1 Global Oral Proteins and Peptides Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Linaclotide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Plecanatide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Calcitonin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Insulin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Octreotide Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Oral Proteins and Peptides Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Gastric & Digestive Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Bone Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Hormonal Disorders Consumption Forecast and Growth Rate (2022-2028)
11 Global Oral Proteins and Peptides Import and Export Analysis (Top 5 Countries)
-
11.1 Global Oral Proteins and Peptides Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Oral Proteins and Peptides Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Oral Proteins and Peptides Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Oral Proteins and Peptides Market Competitive Analysis
-
14.1 Johnson & Johnson
-
14.1.1 Johnson & Johnson Company Details
-
14.1.2 Johnson & Johnson Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson & Johnson Oral Proteins and Peptides Product and Service
-
14.2 ZydusCadilla Healthcare
-
14.2.1 ZydusCadilla Healthcare Company Details
-
14.2.2 ZydusCadilla Healthcare Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 ZydusCadilla Healthcare Oral Proteins and Peptides Product and Service
-
14.3 Abbott Laboratories
-
14.3.1 Abbott Laboratories Company Details
-
14.3.2 Abbott Laboratories Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Abbott Laboratories Oral Proteins and Peptides Product and Service
-
14.4 Sanofi-Aventis LLC
-
14.4.1 Sanofi-Aventis LLC Company Details
-
14.4.2 Sanofi-Aventis LLC Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sanofi-Aventis LLC Oral Proteins and Peptides Product and Service
-
14.5 Novartis AG
-
14.5.1 Novartis AG Company Details
-
14.5.2 Novartis AG Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis AG Oral Proteins and Peptides Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Oral Proteins and Peptides
-
Figure Oral Proteins and Peptides Picture
-
Table Global Oral Proteins and Peptides Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oral Proteins and Peptides Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Oral Proteins and Peptides Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Oral Proteins and Peptides Consumption by Country (2017-2022)
-
Figure United States Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Table Europe Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure China Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Japan Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure India Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure South Korea Oral Proteins and Peptides Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Proteins and Peptides Consumption Forecast by Country (2022-2028)
-
Figure United States Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Oral Proteins and Peptides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Linaclotide Consumption and Growth Rate (2017-2022)
-
Figure Global Plecanatide Consumption and Growth Rate (2017-2022)
-
Figure Global Calcitonin Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Octreotide Consumption and Growth Rate (2017-2022)
-
Figure Global Gastric & Digestive Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Bone Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Hormonal Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Linaclotide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Plecanatide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Calcitonin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Octreotide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastric & Digestive Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bone Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormonal Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Oral Proteins and Peptides Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Oral Proteins and Peptides Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Oral Proteins and Peptides Product and Service
-
Table ZydusCadilla Healthcare (Foundation Year, Company Profile and etc.)
-
Table ZydusCadilla Healthcare Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table ZydusCadilla Healthcare Oral Proteins and Peptides Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Oral Proteins and Peptides Product and Service
-
Table Sanofi-Aventis LLC (Foundation Year, Company Profile and etc.)
-
Table Sanofi-Aventis LLC Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi-Aventis LLC Oral Proteins and Peptides Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Oral Proteins and Peptides Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Oral Proteins and Peptides Product and Service
-
